Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3566795

Documents

Beta release

Statistics of A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma
Statistics for this year
PeriodVisitsDownloads
20266055
Statistics for the last 3 months
PeriodVisitsDownloads
2026-0422
2026-051210
2026-0622